MAPT and Alzheimer disease: In the National Institute on Aging and Alzheimer’s Association Research Framework, the definition of AD has evolved from a syndromal to a biological construct centered on biomarkers categorized as β-amyloid deposition, pathologic tau (Jack et al., 2018).